Trial NCT00030381

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02443
Secondary IDs: CDR0000069160 MC0113 U01CA069912

Last trial update was posted on 2013-01-16

MeSH Interventions

Esorubicin

MeSH Conditions

Amyloidosis Immunoglobulin Light-chain Amyloidosis

Other Conditions

Primary Systemic Amyloidosis

Stopping Reasons

Administratively complete.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID